InsiderTrades.com logo
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.
Russell Barrans net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Russell Barrans Biography and Net Worth

Insider of Evofem Biosciences
Russell (Russ) Barrans serves as Chief Commercial Officer of the Company. Mr. Barrans has over 26 years in the women’s healthcare pharmaceuticals and biotechnology space. As the Chief Commercial Officer, he is responsible for the commercial launch and lifecycle management of the Evofem product portfolio, oversees manufacturing and supply chain, and provides executive leadership to the sales and marketing team. Prior to joining Evofem, Mr. Barrans was the Senior Director of Women’s Healthcare Marketing for Teva Pharmaceuticals from 2012 to June 2015. With significant tenure in life sciences and pharmaceutical companies, Mr. Barrans has held senior level positions at global and domestic companies including Bayer Healthcare and Wyeth Pfizer (formerly Wyeth), as well as, being Chief Executive Officer of FusionRx, a strategic consulting firm servicing biotech and pharmaceutical brands of which Mr. Barrans was the founding partner. Mr. Barrans has overseen directed the launch of over half a dozen brands worldwide including the launch of Mirena, and Plan B One-Step OTC.

What is Russell Barrans' net worth?

The estimated net worth of Russell Barrans is at least $36.73 as of June 11th, 2021. Mr. Barrans owns 3,748 shares of Evofem Biosciences stock worth more than $37 as of November 22nd. This net worth estimate does not reflect any other investments that Mr. Barrans may own. Learn More about Russell Barrans' net worth.

How do I contact Russell Barrans?

The corporate mailing address for Mr. Barrans and other Evofem Biosciences executives is 12400 HIGH BLUFF DRIVE SUITE 600, SAN DIEGO CA, 92130. Evofem Biosciences can also be reached via phone at (858) 550-1900 and via email at [email protected]. Learn More on Russell Barrans' contact information.

Has Russell Barrans been buying or selling shares of Evofem Biosciences?

Russell Barrans has not been actively trading shares of Evofem Biosciences over the course of the past ninety days. Most recently, on Friday, June 11th, Russell Barrans bought 145 shares of Evofem Biosciences stock. The stock was acquired at an average cost of $142.50 per share, with a total value of $20,662.50. Following the completion of the transaction, the insider now directly owns 3,748 shares of the company's stock, valued at $534,090. Learn More on Russell Barrans' trading history.

Who are Evofem Biosciences' active insiders?

Evofem Biosciences' insider roster includes Russell Barrans (Insider), Justin File (CFO), Alexander Fitzpatrick (General Counsel), Kim Kamdar (Director), Anthony O'Brien (Director), Saundra Pelletier (CEO), and Lisa Rarick (Director). Learn More on Evofem Biosciences' active insiders.

Russell Barrans Insider Trading History at Evofem Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/11/2021Buy145$142.50$20,662.503,748View SEC Filing Icon  
9/10/2020Buy8$338.75$2,710.002,208View SEC Filing Icon  
1/16/2020Sell12$812.50$9,750.001,570View SEC Filing Icon  
11/21/2018Buy2$443.75$887.50View SEC Filing Icon  
8/10/2018Buy29$247.50$7,177.50View SEC Filing Icon  
See Full Table

Russell Barrans Buying and Selling Activity at Evofem Biosciences

This chart shows Russell Barrans's buying and selling at Evofem Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Evofem Biosciences Company Overview

Evofem Biosciences logo
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.01
High: $0.01

2 Week Range

Now: $0.01
Low: $0.01
High: $0.23

Volume

308,508 shs

Average Volume

953,531 shs

Market Capitalization

$1.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.